Skip to main content
Back
Watch Compare

Evofem Biosciences, Inc.

Data quality: 100%
EVFM
OTC Manufacturing Chemicals
$0.01
$0.00 (0.00%)
Mkt Cap: 1.13 M
Price
$0.01
Mkt Cap
1.13 M
Day Range
—
52-Week Range
—
Volume
—
Open —
50D / 200D Avg
—
50D / 200D Avg
—

Quick Summary

Key Takeaways

Revenue grew 25.09% annually over 5 years — strong growth
Negative free cash flow of -2.00 M
P/E of 2.88 — trading at a low valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 20.86%
Capital efficient — spends only 0.02% of revenue on capex
Interest coverage of 1.43× — tight debt servicing

Growth

Revenue Growth (5Y)
25.09%
Above sector avg (1.82%)
Revenue (1Y)4.23%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
N/A
ROICN/A
Net Margin1.94%
Op. Margin16.71%

Safety

Debt / Equity
N/A
Current Ratio0.10
Interest Coverage1.43

Valuation

PE (TTM)
2.88
Above sector avg (-1.49)
P/B RatioN/A
EV/EBITDA0.42
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1385 peers)
Metric Stock Sector Median
P/E 2.9 -1.5
P/B — 1.6
ROE % — -54.5
Net Margin % 1.9 -41.5
Rev Growth 5Y % 25.1 1.8
D/E — 0.3

Analyst Price Target

No analyst coverage available

Earnings Estimates

No forward estimates available

Earnings Surprises

Last 1 quarter
Quarter Est. EPS Actual EPS Surprise
Q42023 -$0.61 -$0.44 +27.9%

All Fundamental Metrics
Growth
Revenue Growth (1Y) 4.23% Revenue Growth (3Y) 5.25%
Earnings Growth (1Y) N/A Earnings Growth (3Y) -91.41%
Revenue Growth (5Y) 25.09% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 20.18 M Net Income (TTM) 391,000.0
ROE N/A ROA 2.77%
Gross Margin N/A Operating Margin 16.71%
Net Margin 1.94% Free Cash Flow (TTM) -2.00 M
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0.10
Interest Coverage 1.43 Asset Turnover 1.43
Working Capital -70.27 M Tangible Book Value -80.30 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio 2.88 Forward P/E N/A
P/B Ratio N/A P/S Ratio 0.06
PEG Ratio N/A Forward PEG N/A
EV/EBITDA 0.42 Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -177.27%
Market Cap 1.13 M Enterprise Value 1.42 M
Per Share
EPS (Diluted TTM) 0.00 Revenue / Share 0.16
FCF / Share -0.02 OCF / Share -0.02
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0.02% FCF Conversion -510.74%
SBC-Adj. FCF -2.32 M Growth Momentum -20.86

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 20.18 M 19.36 M 18.22 M 16.84 M 8.24 M
Net Income 391,000.0 -8.86 M 52.98 M -76.70 M -205.19 M
EPS (Diluted) 0.00 -0.12 0.05 -1.34 -1.58
Gross Profit — — — — —
Operating Income 3.37 M -7.68 M -17.85 M -84.12 M -166.80 M
EBITDA — — — — —
R&D Expenses — 1.85 M 2.94 M 25.03 M 33.13 M
SG&A Expenses — — — — —
D&A — — 477,000.0 1.02 M 1.02 M
Interest Expense 2.37 M 2.24 M 2.27 M 2.18 M 2.67 M
Income Tax 2,000.0 17,000.0 17,000.0 44,000.0 17,000.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 20.27 M 23.79 M 10.55 M 25.16 M 42.51 M
Total Liabilities 89.71 M 90.26 M 72.47 M 96.96 M 142.09 M
Shareholders' Equity -74.34 M -71.26 M -66.51 M -71.80 M -104.32 M
Total Debt 147,000.0 135,000.0 — — —
Cash & Equivalents 578,000.0 — 2.77 M 2.77 M 7.73 M
Current Assets 15.28 M 13.61 M 9.21 M 12.70 M 30.14 M
Current Liabilities 84.82 M 80.45 M 72.46 M 93.83 M 137.66 M